GLP2-T

Price range: $79 through $179

Tirzepatide is a dual GIP and GLP-1 receptor agonist studied as a tool compound in incretin-receptor signaling research. Experimental systems examine receptor co-activation, downstream GPCR-mediated signaling cascades, and pathway-level biomarker responses. All references are confined to non-clinical laboratory investigation.

  • $79 / month — Save 10%

Description

What It Is Tirzepatide is a synthetic peptide studied as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor in experimental systems.
What It’s Derived From Tirzepatide is engineered from a modified incretin-mimetic peptide sequence incorporating structural elements that enable receptor engagement at both GIPR and GLP-1R. A fatty-acid side-chain modification enhances molecular stability and prolongs activity in controlled laboratory models.
What Research Focuses On Research evaluates tirzepatide in in vitro and in vivo experimental models investigating incretin receptor pharmacology, G-protein–coupled receptor (GPCR) signaling dynamics, receptor co-activation mechanisms, intracellular cAMP-mediated pathways, and downstream metabolic signaling biomarkers under defined preclinical conditions.

Additional information

Weight 0.0125 lbs
Dimensions 0.625 × 0.625 × 1.5 in
Dosage

10mg, 20mg, 30mg

Reviews

There are no reviews yet.

Be the first to review “GLP2-T”

Your email address will not be published. Required fields are marked *